NeuroSense Therapeutics Ltd. Shareholders' Equity
NeuroSense Therapeutics Ltd. (NRSN) had Shareholders' Equity of -$1.56 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-31
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.56M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$519.00K.
- 2024-12-31: Stockholders' Equity Attributable to Parent $2.58M.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$1.70M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | -$1.56M 20-F · filed 2026-03-31 |
| 2025-06-30 | -$519.00K 6-K · filed 2025-08-01 |
| 2024-12-31 | $2.58M 20-F · filed 2026-03-31 |
| 2024-06-30 | -$1.70M 6-K · filed 2025-08-01 |
| 2023-12-31 | -$1.76M 20-F · filed 2026-03-31 |
| 2023-06-30 | $1.27M 6-K · filed 2024-09-30 |
| 2022-12-31 | $5.84M 20-F · filed 2026-03-31 |
| 2021-12-31 | $10.83M 20-F · filed 2025-04-07 |
| 2020-12-31 | $659.00K 6-K · filed 2024-06-17 |